Cargando…
Biocomputational Screening of Natural Compounds against Acetylcholinesterase
Alzheimer’s disease (AD) is the most common form of dementia and is characterized by irreversible and progressive neurodegeneration. Cholinergic dysfunction has been reported in AD, and several cholinesterase inhibitors, including natural compounds and synthetic analogs, have been developed to treat...
Autores principales: | Ahmad, Syed Sayeed, Khan, Mohd Babu, Ahmad, Khurshid, Lim, Jeong-Ho, Shaikh, Sibhghatulla, Lee, Eun-Ju, Choi, Inho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125523/ https://www.ncbi.nlm.nih.gov/pubmed/33946559 http://dx.doi.org/10.3390/molecules26092641 |
Ejemplares similares
-
A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
por: Shaikh, Sibhghatulla, et al.
Publicado: (2021) -
Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach
por: Ali, Shahid, et al.
Publicado: (2022) -
Cross-Talk Between Extracellular Matrix and Skeletal Muscle: Implications for Myopathies
por: Ahmad, Khurshid, et al.
Publicado: (2020) -
Computational Identification of Dithymoquinone as a Potential Inhibitor of Myostatin and Regulator of Muscle Mass
por: Ahmad, Syed Sayeed, et al.
Publicado: (2021) -
Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study
por: Shaikh, Sibhghatulla, et al.
Publicado: (2023)